1-3 of 3
Elyn R. Riedel, MA
Close
Sort by
Journal Articles

Outcome of Patients with Multiple Myeloma Treated with Autologous Stem Cell Transplantation in the Era of Novel Therapies.

Hani Hassoun, MD, Heather Landau, MD, Chirag Surti, Nelly G. Adel, PharmD, Xiaoyu Jia, MS, Elyn R Riedel, MA, Bhutani Manisha, MD, Raymond Comenzo, MD, Alexander Lesokhin, MD, David J. Chung, MD, PhD, Jennifer Ciminiello, NP, Emily McCullagh, RN, NP-C, OCN, Stephen D Nimer, MD
Journal: Blood
Blood (2009) 114 (22): 1865.
https://doi.org/10.1182/blood.V114.22.1865.1865
Published: 2009
Journal Articles

High Prevalence of Chronic Health Conditions in Survivors of Hodgkin Lymphoma Treated during Adulthood.

Matthew J. Matasar, MD, MS, John N. Butos, BA, Elyn R. Riedel, MA, Jennifer S. Ford, PhD, David M. Weinstock, MD, PhD, Kevin C. Oeffinger, MD, David J. Straus, MD
Journal: Blood
Blood (2007) 110 (11): 4390.
https://doi.org/10.1182/blood.V110.11.4390.4390
Published: 2007
Journal Articles

The Serum Free Light Chain Ratio after One or Two Cycles of Treatment Is Highly Predictive of the Magnitude of Final Response in Patients Undergoing Initial Treatment for Multiple Myeloma.

Hani Hassoun, MD, Lilian Reich, MD, Virginia M. Klimek, MD, Madhav Dhodapkar, MD, Adam Cohen, MD, Tarun Kewalramani, MD, Elyn R. Riedel, MA, Cyrus V. Hedvat, MD, Julie Teruya-Feldstein, MD, Daniel A. Filippa, MD, Martin Fleisher, PhD, Stephen D. Nimer, MD, Raymond L. Comenzo, MD
Journal: Blood
Blood (2005) 106 (11): 3481.
https://doi.org/10.1182/blood.V106.11.3481.3481
Published: 2005